| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/18/2004 | WO2002103024A3 Stabilized proteins with engineered disulfide bonds |
| 03/18/2004 | WO2002090570A3 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 03/18/2004 | WO2002077195A3 Plasmodium falciparum ama-1 protein and uses thereof |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053405 Matrix reactor and a method for producing products in said reactor |
| 03/18/2004 | US20040053393 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 03/18/2004 | US20040053390 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins |
| 03/18/2004 | US20040053380 Process for the preparation of beta-keto aliphatic acid ester |
| 03/18/2004 | US20040053370 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 03/18/2004 | US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders |
| 03/18/2004 | US20040053364 Genetically engineered immunoglobulin receptor for modulating humoral response in transplant patients |
| 03/18/2004 | US20040053363 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053362 Preparing fusion protein comprising multiple functional protein domains via homologous recombination |
| 03/18/2004 | US20040053360 Preparing proteolytic polypeptide comprising amino acid attachment at carboxy-terminal for reducing odors generated when washing textiles solied with milk fat |
| 03/18/2004 | US20040053359 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2004 | US20040053344 Using human leukocyte antigen protein-f to classify and identify cell proliferative disorders |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053282 Diagnosing atopic dermatitis via intersectin-2 gene expression; animal models for inflammatory response |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053269 Proteases |
| 03/18/2004 | US20040053233 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
| 03/18/2004 | US20040053224 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/18/2004 | US20040052869 Orally ingestible preparation of mistletoe lectins and method |
| 03/18/2004 | US20040052816 Recombinant protective protein from streptococcus pneumoniale |
| 03/18/2004 | US20040052809 Atherosclerosis; apolipoproteins; induce immunology response |
| 03/18/2004 | US20040052786 Erbb4 antagonists |
| 03/18/2004 | US20040052779 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 03/18/2004 | US20040052769 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 03/18/2004 | US20040052758 Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle |
| 03/18/2004 | DE10241152A1 Tubulysin-Biosynthese-Gene Tubulysin biosynthesis genes |
| 03/18/2004 | CA2801911A1 Antibody against secreted n-terminal peptide of gpc3 present in blood |
| 03/18/2004 | CA2498243A1 Method for isolating and culturing unculturable microorganisms |
| 03/18/2004 | CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | CA2497411A1 Methods for identifying antimicrobial compounds |
| 03/18/2004 | CA2496888A1 Epitope sequences |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/17/2004 | EP1398385A1 Assay using marked microbial host cell strains |
| 03/17/2004 | EP1398383A1 Protein production method |
| 03/17/2004 | EP1398377A1 Growth differentation Factor-7 |
| 03/17/2004 | EP1398326A2 Monoclonal antibodies against recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 03/17/2004 | EP1398325A1 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/17/2004 | EP1398038A1 Botulinum toxin pharmaceutical compositions |
| 03/17/2004 | EP1397515A2 Nucleotide sequences involved in plant disease resistance |
| 03/17/2004 | EP1397500A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 03/17/2004 | EP1397494A2 Fungal gene cluster associated with pathogenesis |
| 03/17/2004 | EP1397493A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/17/2004 | EP1397492A2 Modified and stabilized gdf propeptides and uses thereof |
| 03/17/2004 | EP1397151A2 Wnv core protein/capsid interacting protein and uses of the same |
| 03/17/2004 | EP1356076A4 Methods and compositions for extracting proteins from cells |
| 03/17/2004 | EP0975775B1 Regulatory system for inducible expression of genes with lambdoid promoters |
| 03/17/2004 | EP0952981B1 Method for producing a correctly folded, biological active recombinant protein |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | EP0866655B1 Murine model for human carcinoma |
| 03/17/2004 | EP0663950B1 Cellulase variants |
| 03/17/2004 | EP0573611B1 Improved epitode displaying phage |
| 03/17/2004 | CN1483080A Fermentative production of D-p-hydroxyphenylglycine and D-phenylglycine |
| 03/17/2004 | CN1483041A GLP-1 fusion protein |
| 03/17/2004 | CN1482255A Method for producing protein feed by fermenting the waste water from saponin production |
| 03/17/2004 | CN1482139A Mucroslysin protein and gene thereof |
| 03/17/2004 | CN1481895A Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 03/17/2004 | CN1481894A Drug composition, its preparation method and use |
| 03/17/2004 | CN1142281C Production method of recombined erythropoietin preparation |
| 03/17/2004 | CN1142179C Multifunctional mycoprotein product for plant and its prepn |
| 03/17/2004 | CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706870 Nucleic acids encoding CTLA-8; and related reagents |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706495 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 03/16/2004 | US6706265 Immunosuppressing graft rejection |
| 03/16/2004 | US6706264 Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y |
| 03/16/2004 | CA2136961C Bnp antibody and immunoassay using it |
| 03/16/2004 | CA2122837C Method for refolding igf-1 to active conformation |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020653A2 Analytical method for the determination of infant formula protein digestibility in vitro |
| 03/11/2004 | WO2004020646A1 Method for extracting proteins |
| 03/11/2004 | WO2004020639A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/11/2004 | WO2004020609A2 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
| 03/11/2004 | WO2004020585A2 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 03/11/2004 | WO2004020579A2 Method of humanizing immune system molecules |
| 03/11/2004 | WO2004020470A1 Process for producing collagen treated with cysteine protease and collagen treated with cysteine protease |
| 03/11/2004 | WO2004020456A2 Selecting therapeutic human monoclonal antibodies from disease-specific libraries |
| 03/11/2004 | WO2004020451A1 Group b streptococcal phage lysin |
| 03/11/2004 | WO2004019990A1 Therapeutic system targeting pathogen proteases and uses thereof |
| 03/11/2004 | WO2004019893A2 Modulators of angiogenesis |
| 03/11/2004 | WO2004019878A2 Adzymes and uses thereof |
| 03/11/2004 | WO2004019872A2 Oral delivery of modified transferrin fusion proteins |
| 03/11/2004 | WO2004019860A2 Formulations of modified antibodies and methods of making the same |
| 03/11/2004 | WO2004003217A8 Glutathione production |
| 03/11/2004 | WO2003099862A8 Export and modification of (poly)peptides in the lantibiotic way |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003078637A3 Optimizing glycan processing in plants |
| 03/11/2004 | WO2003068933A3 Optimization of gene sequences of virus-like particles for expression in insect cells |